{"id":"https://openalex.org/W2017520924","doi":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","title":"Continuous infusion of FVIII and FIX concentrates:in vitroanalysis of clinically relevant parameters","display_name":"Continuous infusion of FVIII and FIX concentrates:in vitroanalysis of clinically relevant parameters","publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W2017520924","doi":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","mag":"2017520924","pmid":"https://pubmed.ncbi.nlm.nih.gov/10215943"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2516.1999.00210.x","doi":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110089665","display_name":"K. B. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"K. B. Thomas","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016403288","display_name":"W. Urbancik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"W. Urbancik","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048575193","display_name":"Peter L. Turecek","orcid":"https://orcid.org/0000-0002-6161-1556","observed_orcids":["https://orcid.org/0000-0002-6161-1556"]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"P. L. Turecek","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063894554","display_name":"Herbert Gritsch","orcid":"https://orcid.org/0000-0002-7251-6941","observed_orcids":["https://orcid.org/0000-0002-7251-6941"]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"H. Gritsch","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081509172","display_name":"J\u00f6rg D. Schreiber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"J. Schreiber","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047997527","display_name":"Alfred Weber","orcid":"https://orcid.org/0000-0002-0423-3851","observed_orcids":["https://orcid.org/0000-0002-0423-3851"]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"A. Weber","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007552774","display_name":"W. Sch\u00f6nhofer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"W. Sch\u00f6nhofer","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Strauss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"M. Strauss","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053813820","display_name":"Y. Linnau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Y. Linnau","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076151217","display_name":"Axel Schoppmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101150","display_name":"Baxter (Austria)","ror":"https://ror.org/013xmn143","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210101150","https://openalex.org/I99484792"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"A. Schoppmann","raw_affiliation_strings":["Hyland Immuno Division, Baxter Healthcare, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hyland Immuno Division, Baxter Healthcare, Vienna, Austria","institution_ids":["https://openalex.org/I4210101150"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076151217"],"corresponding_institution_ids":["https://openalex.org/I4210101150"],"apc_list":{"value":4760,"currency":"USD","value_usd":4760},"apc_paid":null,"fwci":0.3411,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.56344426,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"1","first_page":"17","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viii-concentrate","display_name":"factor VIII concentrate","score":0.8169999718666077},{"id":"https://openalex.org/keywords/factor-ix-concentrate","display_name":"factor IX concentrate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.9629999995231628},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.8539999723434448},{"id":"https://openalex.org/keywords/thrombogenicity","display_name":"thrombogenicity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/sterility","display_name":"sterility","score":0.6970000267028809},{"id":"https://openalex.org/keywords/factor-viii-c","display_name":"factor VIII:C","score":0.5450000166893005},{"id":"https://openalex.org/keywords/ristocetin-cofactor-activity","display_name":"ristocetin cofactor activity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hemophilia-treatment","display_name":"hemophilia treatment","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.6545637845993042},{"id":"https://openalex.org/C2776649359","wikidata":"https://www.wikidata.org/wiki/Q7798338","display_name":"Thrombogenicity","level":3,"score":0.6251295208930969},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.5693855285644531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5538309812545776},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.5336426496505737},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4590661823749542},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.4180666208267212},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4159630537033081},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3481292426586151},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3138285279273987},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.2520836591720581},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25043201446533203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2054291069507599},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17946231365203857},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1282210350036621},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005164","descriptor_name":"Factor IX","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005164","descriptor_name":"Factor IX","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007260","descriptor_name":"Infusion Pumps","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013242","descriptor_name":"Sterilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019851","descriptor_name":"Thrombophilia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2516.1999.00210.x","doi":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2516.1999.00210.x","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},{"id":"pmid:10215943","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10215943","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia : the official journal of the World Federation of Hemophilia","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306534","display_name":"W.E. Upjohn Institute for Employment Research","ror":"https://ror.org/00kqye711"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W38919216","https://openalex.org/W84925487","https://openalex.org/W175393005","https://openalex.org/W207578375","https://openalex.org/W1504674459","https://openalex.org/W1904020067","https://openalex.org/W1974118967","https://openalex.org/W1979944276","https://openalex.org/W1983129316","https://openalex.org/W1986859389","https://openalex.org/W1989754377","https://openalex.org/W2002531170","https://openalex.org/W2008004101","https://openalex.org/W2011649613","https://openalex.org/W2014586564","https://openalex.org/W2014973808","https://openalex.org/W2053635159","https://openalex.org/W2063119299","https://openalex.org/W2072230435","https://openalex.org/W2075548519","https://openalex.org/W2075651565","https://openalex.org/W2083021192","https://openalex.org/W2093291439","https://openalex.org/W2124382614","https://openalex.org/W2136022380","https://openalex.org/W2137846570","https://openalex.org/W2161680269","https://openalex.org/W2395916949","https://openalex.org/W2404846762","https://openalex.org/W2406715252","https://openalex.org/W2407574960","https://openalex.org/W2410799309","https://openalex.org/W2415232981","https://openalex.org/W2415863444","https://openalex.org/W2421629999","https://openalex.org/W2426395611","https://openalex.org/W2430768242","https://openalex.org/W2431575515","https://openalex.org/W2442123286","https://openalex.org/W2977024364","https://openalex.org/W4230915316","https://openalex.org/W4285719527","https://openalex.org/W4319053052"],"related_works":["https://openalex.org/W2555337815","https://openalex.org/W2161680269","https://openalex.org/W2588818250","https://openalex.org/W2136022380","https://openalex.org/W2426395611","https://openalex.org/W2066014986","https://openalex.org/W2170423754","https://openalex.org/W2166478141","https://openalex.org/W2088362088","https://openalex.org/W6959274904"],"abstract_inverted_index":{"A":[0],"high":[1,18,244],"purity":[2,19,245],"factor":[3,20],"VIII/von":[4],"Willebrand":[5],"Factor":[6],"(FVIII/vWF)":[7],"concentrate":[8,23,170],"(IMMUNATE":[9],"[STIM":[10,25],"plus])":[11,26],"(n":[12,27],"=":[13,28],"6":[14],"batches),":[15,30],"and":[16,48,89,95,109,125,136,161,165,190,202,256],"a":[17,146,178],"IX":[21],"(FIX)":[22],"(IMMUNINE":[24],"7":[29],"were":[31,46,79,83,240,258],"assessed":[32,153],"in":[33,53,154,159,162,242,251],"vitro":[34,163,252],"for":[35,110,131,200,205,207,263],"their":[36],"applicability":[37],"to":[38,43,112,209,260],"continuous":[39,44,266],"infusion.":[40,267],"Parameters":[41],"pertinent":[42],"infusion":[45,69],"investigated":[47],"included":[49],"stability,":[50],"sterility":[51],"and,":[52],"the":[54,58,104,107,173,185,243,250],"case":[55],"of":[56,60,106,198,214,224],"FIX,":[57],"generation":[59],"potentially":[61],"thrombogenic":[62,238],"components.":[63],"Four":[64],"stationary":[65],"or":[66,75,216,226,234],"transportable":[67],"mini":[68],"pumps,":[70],"equipped":[71],"with":[72],"polyethylene,":[73],"polypropylene":[74],"polyvinylchloride":[76],"plastic":[77,229],"components":[78,239],"used.":[80],"The":[81,115,138,188],"concentrates":[82,181],"reconstituted":[84],"without":[85],"extra":[86],"filling":[87],"volume":[88],"perfused":[90,189],"at":[91,103],"12.5":[92],"mL":[93,97],"h-1":[94],"1":[96],"h-1;":[98],"sampling":[99],"was":[100,120,129,143,152,218],"carried":[101],"out":[102],"start":[105],"experiment":[108],"up":[111,208],"48":[113,210],"h.":[114,211],"FVIII":[116,225],"procoagulant":[117],"activity":[118,141,199],"(FVIII:C)":[119],"assayed":[121],"by":[122,145,265],"amidolytic,":[123],"1-stage":[124,147],"2-stage":[126],"assays;":[127],"vWF":[128],"examined":[130],"ristocetin":[132],"cofactor":[133],"activity,":[134],"antigen":[135],"multimers.":[137],"FIX":[139,227,246,257],"coagulation":[140,148],"(FIX:C)":[142],"determined":[144],"assay;":[149],"thrombogenicity":[150],"potential":[151],"vivo":[155],"(Wessler":[156],"stasis":[157],"model":[158],"rabbits)":[160],"(FIXa":[164],"nonactivated":[166],"thromboplastin":[167],"time).":[168],"Reconstituted":[169],"incubated":[171],"under":[172,249],"same":[174],"conditions":[175,253],"served":[176],"as":[177],"control.":[179],"Both":[180],"remained":[182,193],"sterile":[183],"throughout":[184],"testing":[186],"period.":[187],"control":[191],"samples":[192],"stable,":[194],"retaining":[195],"over":[196,203],"95%":[197],"FVIII:C":[201,215],"90%":[204],"FIX:C":[206,217],"Intermittent":[212],"decrease":[213],"not":[219],"observed,":[220],"suggesting":[221],"no":[222],"adsorption":[223],"onto":[228],"surfaces":[230],"during":[231],"either":[232],"short":[233],"long-term":[235],"exposure.":[236],"No":[237],"detected":[241],"concentrate.":[247],"Thus,":[248],"used,":[254],"FVIII/vWF":[255],"found":[259],"be":[261],"suitable":[262],"administration":[264]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}